Back to Directory
Pegfilgrastim
Performance & EnduranceLong-acting PEGylated G-CSF for chemotherapy support, single dose per cycle.
Key Benefits
- ✓Single dose per chemo cycle
- ✓Prevents febrile neutropenia
- ✓More convenient than daily filgrastim
- ✓Long-acting G-CSF
- ✓Reduces infection risk
Dosing Information
Dosage Range
6 mg
Frequency
Once per chemo cycle
Typical Duration
One dose per cycle
Detailed Protocol
Administered via subcutaneous injection once per chemotherapy cycle, at least 24 hours after chemotherapy. Single dose replaces 10+ daily filgrastim injections. Prescription only.
About Pegfilgrastim
Pegfilgrastim (Neulasta) is filgrastim conjugated to PEG for extended half-life. Single injection provides neutrophil support for entire chemotherapy cycle. FDA-approved to reduce febrile neutropenia risk.
Research Notes
FDA-approved in 2002. Dramatically improved convenience vs daily G-CSF. On-body injector (Onpro) allows automatic timed administration. Standard in oncology. Biosimilars available.
Potential Side Effects
- •Bone pain (very common)
- •Injection site reactions
- •Splenic issues (rare)
- •Similar to filgrastim
Always consult with a healthcare professional before starting any peptide therapy.